Optas LLC cut its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 34.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,227 shares of the company’s stock after selling 1,669 shares during the quarter. Optas LLC’s holdings in AbbVie were worth $500,000 […]